Product Information

DICLEGIS DR 10-10 MG TABLET is a brand product labeled by Duchesnay USA, Inc., priced at $1.6758 per EA under NDC 55494010010. Its NADAC has been published 671 times since Nov 28, 2013.

FDA first approved this application on Apr 8, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the doxylamine succinate and pyridoxine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DICLEGIS DR 10-10 MG TABLET

doxylamine succinate and pyridoxine hydrochloride
$1.6758per EA
High Outlier

Strength

10; 10 mg/1; mg/1

NDC

55494010010

Classification

Brand

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

9/23/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021876

FDA Approved

4/8/2013

TE Code

AB

On Market Since

5/15/2013

Pharmacological Classes

Analogs/Derivatives [Chemical/Ingredient]
Antihistamine
Histamine Receptor Antagonists
Vitamin B 6 [Chemical/Ingredient]
Vitamin B6 Analog

Price Statistics

The NADAC for DICLEGIS DR 10-10 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 63.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6758 per EA
All-time high$6.5992 (Mar 11, 2020)
All-time low$1.6714 (Aug 19, 2026)
52-week high$1.9957
52-week low$1.6714
Median price$5.2322
Average price$4.9608
Largest weekly change-40.1% (Apr 10, 2024)
Weeks tracked671
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.3%

3M

-0.1%

6M

-0.1%

1Y

-16.0%

3Y

-67.7%

5Y

-67.8%

All

-63.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 25%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DICLEGIS DR 10-10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DICLEGIS DR 10-10 MG TABLET, manufactured by Duchesnay USA, Inc., is $1.6758 per EA (NDC 55494010010), effective Sep 30, 2026.

How has the price of DICLEGIS DR 10-10 MG TABLET changed over time?

Over the history we have for it, the NADAC for DICLEGIS DR 10-10 MG TABLET has declined 63.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DICLEGIS DR 10-10 MG TABLET?

Since Nov 28, 2013, the NADAC for DICLEGIS DR 10-10 MG TABLET has ranged from a low of $1.6714 (Aug 19, 2026) to a high of $6.5992 (Mar 11, 2020), with a median of $5.2322 per EA.

Are there cheaper alternatives to DICLEGIS DR 10-10 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXYLAMINE-PYRIDOXINE 10-10 MG, is $1.2627 per EA — about 25% below DICLEGIS DR 10-10 MG TABLET.

Who manufactures DICLEGIS DR 10-10 MG TABLET?

DICLEGIS DR 10-10 MG TABLET (NDC 55494010010) is labeled by Duchesnay USA, Inc., and CMS classifies it as a brand product.